Peripheral effects of FAAH deficiency on fuel and energy homeostasis: Role of dysregulated lysine acetylation

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Vaitheesvaran, Bhavapriya ^a   Yang, Li ^b   Hartil, Kirsten ^a   Glaser, Sherrye ^c   Yazulla, Stephen ^c   Bruce, James E ^d   Kurland, Irwin J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c Stony Brook University   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; FATTY ACID AMIDASE; LYSINE; MALATE DEHYDROGENASE; ACETYL COENZYME A; AMIDASE; FATTY-ACID AMIDE HYDROLASE; GLUCOSE;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME POLYMORPHISM; ESSENTIAL FATTY ACID DEFICIENCY; GENE MUTATION; GLUCOSE METABOLISM; GLYCOLYSIS; HOMEOSTASIS; HYDROLYSIS; IMMUNOPRECIPITATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; LIVER FUNCTION; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PHENOTYPE; PROTEIN EXPRESSION; ANIMAL; ENERGY METABOLISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; METABOLISM; MOUSE MUTANT; OBESITY;

MUS;

ACETYL COENZYME A; ACETYLATION; AMIDOHYDROLASES; ANIMALS; ENERGY METABOLISM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIVER; LYSINE; MICE; MICE, KNOCKOUT; OBESITY;

EID: 84863338534     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033717     Document Type: Article

References (65)

1. Das UN, (2010) Obesity: genes, brain, gut, and environment. Nutrition 26: 459-473.
2. Astrup A, Finer N, (2000) Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'? Obes Rev 1: 57-59.
3. Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, et al. (2009) Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther 330: 902-910.
4. Despres JP, (2007) The endocannabinoid system: a new target for the regulation of energy balance and metabolism. Crit Pathw Cardiol 6: 46-50.
5. Tourino C, Oveisi F, Lockney J, Piomelli D, Maldonado R, (2010) FAAH deficiency promotes energy storage and enhances the motivation for food. Int J Obes (Lond) 34: 557-568.
6. Piomelli D, (2005) The endocannabinoid system: a drug discovery perspective. Curr Opin Investig Drugs 6: 672-679.
7. Engeli S, Jordan J, (2006) The endocannabinoid system: body weight and metabolic regulation. Clin Cornerstone 8 (Suppl 4): S24-35.
8. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Janke J, et al. (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54: 2838-2843.
9. Bluher M, Engeli S, Kloting N, Berndt J, Fasshauer M, et al. (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053-3060.
10. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115: 1298-1305.
11. Cota D, (2008) Role of the endocannabinoid system in energy balance regulation and obesity. Front Horm Res 36: 135-145.
12. Di Marzo V, (2011) Endocannabinoids: an appetite for fat. Proc Natl Acad Sci U S A 108: 12567-12568.
13. Silvestri C, Ligresti A, Di Marzo V, (2011) Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle. Rev Endocr Metab Disord 12: 153-162.
14. Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, et al. (2005) The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 40: 2-14.
15. Di Marzo V, Deutsch DG, (1998) Biochemistry of the Endogenous Ligands of Cannabinoid Receptors. Neurobiology of Disease 5: 386-404.
16. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Martin BR, (1999) Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Curr Med Chem 6: 721-744.
17. Muccioli GG, (2010) Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today.
18. Sipe JC, Scott TM, Murray S, Harismendy O, Simon GM, et al. (2010) Biomarkers of endocannabinoid system activation in severe obesity. PLoS One 5: e8792.
19. Monteleone P, Tortorella A, Martiadis V, Di Filippo C, Canestrelli B, et al. (2008) The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women. Psychoneuroendocrinology 33: 546-550.
20. Kelley DE, (2005) Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest 115: 1699-1702.
21. Galgani J, Ravussin E, (2008) Energy metabolism, fuel selection and body weight regulation. Int J Obes (Lond) 32 (Suppl 7): S109-119.
22. Yang L, Vaitheesvaran B, Hartil K, Robinson AJ, Hoopmann MR, et al. (2011) The fasted/fed mouse metabolic acetylome: n6-acetylation differences suggest acetylation coordinates organ-specific fuel switching. J Proteome Res 10: 4134-4149.
23. Cravatt BF, Saghatelian A, Hawkins EG, Clement AB, Bracey MH, et al. (2004) Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc Natl Acad Sci U S A 101: 10821-10826.
24. Cravatt BF, Lichtman AH, (2003) Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 7: 469-475.
25. Gatta-Cherifi B, Matias I, Vallee M, Tabarin A, Marsicano G, et al. (2011) Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. Int J Obes (Lond).
26. Gaetani S, Kaye WH, Cuomo V, Piomelli D, (2008) Role of endocannabinoids and their analogues in obesity and eating disorders. Eat Weight Disord 13: e42-48.
27. Karaliota S, Siafaka-Kapadai A, Gontinou C, Psarra K, Mavri-Vavayanni M, (2009) Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation. Obesity (Silver Spring) 17: 1830-1838.
28. Matias I, Bisogno T, Di Marzo V, (2006) Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes (Lond) 30 (Suppl 1): S7-S12.
29. Bouaboula M, Hilairet S, Marchand J, Fajas L, Le Fur G, et al. (2005) Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur J Pharmacol 517: 174-181.
30. Vaitheesvaran B, Leroith D, Kurland IJ, (2010) MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity. Diabetologia 53 (10): 2224-32.
31. Vaitheesvaran B, Chueh FY, Xu J, Trujillo C, Saad MF, et al. (2010) Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes. Metabolomics 6: 180-190.
32. Stephens FB, Constantin-Teodosiu D, Greenhaff PL, (2007) New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol 581: 431-444.
33. Zhao S, Xu W, Jiang W, Yu W, Lin Y, et al. (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327: 1000-1004.
34. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, et al. (2010) Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 327: 1004-1007.
35. Guan KL, Xiong Y, (2011) Regulation of intermediary metabolism by protein acetylation. Trends Biochem Sci 36: 108-116.
36. Xu W, Zhao S, (2011) Metabolism is regulated by protein acetylation. pp. 213-218.
37. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, et al. (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 23: 607-618.
38. Zhang J, Sprung R, Pei J, Tan X, Kim S, et al. (2009) Lysine acetylation is a highly abundant and evolutionarily conserved modification in Escherichia coli. Mol Cell Proteomics 8: 215-225.
39. Locasale JW, Cantley LC, (2011) Metabolic flux and the regulation of Mammalian cell growth. Cell Metab 14: 443-451.
40. Baranyai JM, Blum JJ, (1989) Quantitative analysis of intermediary metabolism in rat hepatocytes incubated in the presence and absence of ethanol with a substrate mixture including ketoleucine. Biochem J 258: 121-140.
41. Zhang Y, Agarwal KC, Beylot M, Soloviev MV, David F, et al. (1994) Nonhomogeneous labeling of liver extra-mitochondrial acetyl-CoA. Implications for the probing of lipogenic acetyl-CoA via drug acetylation and for the production of acetate by the liver. J Biol Chem 269: 11025-11029.
42. Mallat A, Lotersztajn S, (2008) Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. Diabetes Metab 34: 680-684.
43. Friedman SL, Nieto N, (2008) Cannabinoids provoke alcoholic steatosis through a conspiracy of neighbors. Cell Metab 7: 187-188.
44. Jeong WI, Osei-Hyiaman D, Park O, Liu J, Batkai S, et al. (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7: 227-235.
45. Shepard BD, Tuma DJ, Tuma PL, (2010) Chronic ethanol consumption induces global hepatic protein hyperacetylation. Alcohol Clin Exp Res 34: 280-291.
46. Snider NT, Walker VJ, Hollenberg PF, (2010) Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Pharmacol Rev 62: 136-154.
47. Glaser ST, Gatley SJ, Gifford AN, (2006) Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. J Pharmacol Exp Ther 316: 1088-1097.
48. Glaser ST, Kaczocha M, (2010) Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain. J Pharmacol Exp Ther 335: 380-388.
49. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, et al. (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313: 352-358.
50. Lee WN, Bassilian S, Ajie HO, Schoeller DA, Edmond J, et al. (1994) In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis. Am J Physiol 266: E699-708.
51. Lee WN, Bassilian S, Guo Z, Schoeller D, Edmond J, et al. (1994) Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis. Am J Physiol 266: E372-383.
52. Diraison F, Pachiaudi C, Beylot M, (1997) Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. J Mass Spectrom 32: 81-86.
53. Brunengraber DZ, McCabe BJ, Kasumov T, Alexander JC, Chandramouli V, et al. (2003) Influence of diet on the modeling of adipose tissue triglycerides during growth. Am J Physiol Endocrinol Metab 285: E917-925.
54. Previs SF, Fatica R, Chandramouli V, Alexander JC, Brunengraber H, et al. (2004) Quantifying rates of protein synthesis in humans by use of 2H2O: application to patients with end-stage renal disease. Am J Physiol Endocrinol Metab 286: E665-672.
55. Dufner DA, Bederman IR, Brunengraber DZ, Rachdaoui N, Ismail-Beigi F, et al. (2005) Using 2H2O to study the influence of feeding on protein synthesis: effect of isotope equilibration in vivo vs. in cell culture. Am J Physiol Endocrinol Metab 288: E1277-1283.
56. Xu J, Chang V, Joseph SB, Trujillo C, Bassilian S, et al. (2004) Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux. Endocrinology 145: 1087-1095.
57. Xu J, Gowen L, Raphalides C, Hoyer KK, Weinger JG, et al. (2006) Decreased hepatic futile cycling compensates for increased glucose disposal in the Pten heterodeficient mouse. Diabetes 55: 3372-3380.
58. Xu J, Lee WN, Phan J, Saad MF, Reue K, et al. (2006) Lipin deficiency impairs diurnal metabolic fuel switching. Diabetes 55: 3429-3438.
59. Xu J, Lee WN, Xiao G, Trujillo C, Chang V, et al. (2003) Determination of a glucose-dependent futile recycling rate constant from an intraperitoneal glucose tolerance test. Anal Biochem 315: 238-246.
60. Xu J, Xiao G, Trujillo C, Chang V, Blanco L, et al. (2002) Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J Biol Chem 277: 50237-50244.
61. Gilibili RR, Kandaswamy M, Sharma K, Giri S, Rajagopal S, et al. (2011) Development and validation of a highly sensitive LC-MS/MS method for simultaneous quantitation of acetyl-CoA and malonyl-CoA in animal tissues. Biomed Chromatogr 25: 1352-1359.
62. Ghoshal AK, Guo T, Soukhova N, Soldin SJ, (2005) Rapid measurement of plasma acylcarnitines by liquid chromatography-tandem mass spectrometry without derivatization. Clinica chimica acta; international journal of clinical chemistry 358: 104-112.
63. Roessner U, Wagner C, Kopka J, Trethewey RN, Willmitzer L, (2000) Technical advance: simultaneous analysis of metabolites in potato tuber by gas chromatography-mass spectrometry. Plant J 23: 131-142.
64. Kind T, Wohlgemuth G, Lee do Y, Lu Y, Palazoglu M, et al. (2009) FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem 81: 10038-10048.
65. Kupke IR, Zeugner S, (1978) Quantitative high-performance thin-layer chromatography of lipids in plasma and liver homogenates after direct application of 0.5-microliter samples to the silica-gel layer. J Chromatogr 146: 261-271.